Table 3. Immunohistochemical evaluation of HMGA2 in thyroid tumors.
Total | HMGA2 positive | HMGA2 negative* | |||
---|---|---|---|---|---|
High† | Moderate‡ | Low§ | |||
Tissue array samples | 87 | ||||
Normal thyroid | 19 | – | – | 2 | 17 |
Follicular adenoma | 14 | – | – | 1 | 13 |
Lymphocytic thyroiditis nodule | 11 | – | – | 6 | 5 |
Follicular carcinoma | 14 | 3 | 2 | 5 | 4 |
Follicular variant of papillary thyroid carcinoma | 9 | 4 | 2 | 1 | 2 |
Papillary thyroid carcinoma | 20 | 7 | 7 | 4 | 2 |
Nonarrayed samples | 38 | ||||
Follicular adenoma | 11 | – | – | 2 | 9 |
Adenomatoid nodule | 10 | – | 1 | 1 | 8 |
Follicular variant of papillary thyroid carcinoma | 7 | 4 | 1 | 1 | 1 |
Papillary thyroid carcinoma | 10 | 5 | 2 | 1 | 2 |
No significant expression.
Expressed in >66% of cell population.
Expressed in 33% to 66% of cell population.
Expressed in <33% of cell population.